Tracked forImpact Factor
Indexed inScopus
22 daysTime to First Decision

Pharmacoepidemiology, Volume 1, Issue 2

September 2022 - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Article

1 Citations

4,283 Views

13 Pages

Medication Use among Immigrants from Syria Living in Western Norway: A Cross-Sectional Study

George Deeb,
Esperanza Diaz,
Svein Haavik and
Angela Lupattelli

Pharmacoepidemiology2022, 1(2), 76-88;https://doi.org/10.3390/pharma1020008

1 September 2022

This cross-sectional study sought to quantify medication use and change in use of prescription-only medications purchased in the past in Syria without medical prescription versus today in Norway in an adult population originating from Syria and livin...

Full Article

Article

4 Citations

2,662 Views

12 Pages

Non-Cardiac Depolarization-Blocking Drugs Are Associated with Increased Risk of Out-of-Hospital Cardiac Arrest in the Community

Talip E. Eroglu,
Marieke T. Blom,
Patrick C. Souverein,
Anthonius de Boer and
Hanno L. Tan

Pharmacoepidemiology2022, 1(2), 64-75;https://doi.org/10.3390/pharma1020007

1 August 2022

Depolarization-blocking drugs (DB drugs) used for cardiac disease increase the risk of cardiac arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]) and out-of-hospital cardiac arrest (OHCA) in specific patient groups. However, it is...

Full Article

Review

2 Citations

2,780 Views

15 Pages

The Complexity in the Diagnosis and Treatment of Symptoms in Electronic Cigarette Users during the COVID-19 Pandemic

Ayesha Rahman Ahmed and
Mahiba Ahmed

Pharmacoepidemiology2022, 1(2), 49-63;https://doi.org/10.3390/pharma1020006

12 July 2022

The issue with the overlapping clinical symptoms from an electronic cigarette (e-cigarette) or vaping product use-associated lung injury (EVALI) and coronavirus disease 2019 (COVID-19) sometimes leads to incorrect diagnosis and, consequently, wrong t...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Pharmacoepidemiology - ISSN 2813-0618

Imprint

Download Flyer